m7FLIPI and targeted sequencing in high‐risk follicular lymphoma

Patients with follicular lymphoma (FL) refractory to front‐line immunochemotherapy (ICT) have a poor overall survival (OS). Gene mutation analysis may be more accurate than classical risk factors to pick out these patients before treatment. This study aimed to describe the prevalence of selected gen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2019-12, Vol.37 (5), p.564-568
Hauptverfasser:	Sorigue, Marc, Oliveira, Anna, Mercadal, Santiago, Tapia, Gustavo, Climent, Fina, Perez‐Roca, Laia, Lorences, Irian, Domingo‐Domenech, Eva, Cabezon, Marta, Navarro, Jose‐Tomas, Gonzalez‐Barca, Eva, Zamora, Lurdes, Ribera, Josep‐María, Sureda, Anna, Armengol, Maria‐Pilar, Sancho, Juan‐Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers, Tumor - genetics EP300 Female follicular lymphoma Gene Expression Profiling - methods Gene sequencing Genes Humans Kaplan-Meier Estimate Lymphoma Lymphoma, Follicular - drug therapy Lymphoma, Follicular - genetics Lymphoma, Follicular - mortality Lymphoma, Follicular - pathology m7FLIPI Male Middle Aged Molecular Targeted Therapy - methods Mutation Point mutation Polymorphism, Single Nucleotide prognosis refractoriness Risk analysis Risk factors sequencing Survival Thermal resistance TP53 Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!